GenapSys, Inc., a pioneering force in the genomics industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2014, the company has rapidly established itself as a leader in next-generation sequencing technology, focusing on making genomic data accessible and affordable for researchers and clinicians alike. GenapSys is renowned for its innovative sequencing platform, which leverages a unique semiconductor-based technology to deliver high-quality genomic data with unprecedented speed and accuracy. This cutting-edge approach not only reduces costs but also enhances the scalability of genomic applications, setting GenapSys apart in a competitive market. With a commitment to advancing personalised medicine and improving healthcare outcomes, GenapSys has achieved notable milestones, including partnerships with leading research institutions and a growing portfolio of intellectual property. As the demand for genomic solutions continues to rise, GenapSys remains at the forefront, driving innovation and transforming the landscape of genomics.
How does GenapSys, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
GenapSys, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GenapSys, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that GenapSys may not have established formal commitments to reduce its carbon footprint or may be in the early stages of developing such initiatives. As the industry increasingly prioritises sustainability, it will be essential for GenapSys to consider implementing measurable climate commitments to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GenapSys, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
